Glaxo to slice $792M more from costs
It’s becoming a pattern here. While reporting its Q4 earnings today, GlaxoSmithKline announced plans to cut hundreds of millions more from its cost structure. And just like the other drugmakers who’ve done the same over the last week, the Glaxo cuts come seemingly despite growth in profits; the company posted a 32 percent increase in profits on revenues of
